TMPRSS2-ERG controls luminal epithelial lineage and antiandrogen sensitivity in PTEN and TP53-mutated prostate cancer

PURPOSE: Deletions or mutations in PTEN and TP53 tumor suppressor genes have been linked to lineage plasticity in therapy-resistant prostate cancer. Fusion-driven overexpression of the oncogenic transcription factor ERG is observed in approximately 50% of all prostate cancers, many of which also har...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Cancer Res
Hlavní autoři: Blee, Alexandra M., He, Yundong, Yang, Yinhui, Ye, Zhenqing, Yan, Yuqian, Pan, Yunqian, Ma, Tao, Dugdale, Joseph, Kuehn, Emily, Kohli, Manish, Jimenez, Rafael, Chen, Yu, Xu, Wanhai, Wang, Liguo, Huang, Haojie
Médium: Artigo
Jazyk:Inglês
Vydáno: 2018
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6139075/
https://ncbi.nlm.nih.gov/pubmed/29844131
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-18-0653
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky